Table 2.
Total number of events and incidence rate with exact 95% Poisson confidence interval for the outcomes of individuals without type 2 diabetes (Non-T2D) and individuals with type 2 diabetes (T2D), respectively, undergoing carotid intervention
| Outcome | Non-T2D (n = 4162) | T2D (n = 1341) | ||
|---|---|---|---|---|
| Events (n) | Incidence rate (per 1000 patients) | Events (n) | Incidence rate (per 1000 patients) | |
| Stroke | 453 | 25.1 (22.8–27.5) | 193 | 35.7 (30.8–41.1) |
| Ischemic stroke | 380 | 20.8 (18.8–23.0) | 166 | 30.3 (25.9–35.3) |
| Hemorrhagic stroke | 68 | 3.5 (2.7–4.5) | 20 | 3.4 (2.1–5.2) |
| Death | 725 | 37.4 (34.7–40.2) | 324 | 54.5 (48.7–60.7) |
| Cardiovascular death | 161 | 8.3 (7.1–9.7) | 89 | 15.0 (12.0–18.4) |
| MACE | 1248 | 82.7 (78.2–87.4) | 551 | 135 (123.4–146.1) |
HR hazard ratio, MACE major adverse cardiovascular events, i.e. non-fatal myocardial infarction, non-fatal stroke and cardiovascular death